We recommend that you upgrade to the latest version of your browser.
A comprehensive investment in the cancer treatment of the future.
Ahus Cancer Centre
The Ahus Cancer Centre is the hospital's central unit for diagnostics, treatment, research, and development in the field of cancer. Our aim is to ensure patients receive a comprehensive, coordinated, and evidence-based treatment offer of high quality – now and in the future.
Through gradual development and strengthening of cancer treatment services, coherent patient pathways and comprehensive cancer care shall be created.
Ahus Development Plan 2040
Ahus Cancer Centre will provide treatment-related research with direct significance for the patient.
Organisation
Cancer Board – strategic management
Ahus Cancer Centre is led by the Cancer Board, which has the overall responsibility for direction, coordination, and priorities in the development of the cancer centre. The Cancer Board consists of directors from divisions responsible for cancer-related areas and is chaired by Erik Borge Skei, Director of the Medical Division at Ahus.
Erik Borge Skei (Chair)
Helge Rørvik Røsjø
Anne Karin Lindahl
Anne Pernille Schjønsby
Janne Pedersen
Kirsten Haugland
Geir Arne Larsen
Christine Lager Nesje (Cancer Society)
Cancer Council – advisory body
The Cancer Council is the professional advisory body of the cancer centre and consists of department heads from cancer-related fields. The Council provides input to the Cancer Board and contributes to ensuring professional anchoring and collaboration in the development work.
Anita Berg Petersen
Anne Helene Edvardsen
Elin Edda Seland Agustdottir
Ellen Elisabeth Brodin
Frode Arnt Olsbø
Frode Harald Eidset
Geir Bøhler
Hilde Christina Stømner
Ida Årving
Ivar Bjarmann Vølstad
Nina Michelle Rolland Krogh
Olav Magnus Søndenå Fredheim
Stig Müller
Ulla Randen
Divisions and departments that are part of the cancer centre
Link list: divisions
Link List: Departments
Character Gallery: Secretariat
Quality Assurance
We work systematically and purposefully to ensure high quality in all aspects of cancer treatment. The cancer centre adheres to national professional standards, participates in external audits, and actively uses inspection reports in our improvement work.
The Cancer Centre and our support functions are regularly subject to audits by regional bodies and supervisory authorities. These reports are important tools in our quality work and demonstrate how we strive for safe and predictable patient care.
The supervision assessed blood collection, testing, processing, storage, and release of blood and blood components, as well as the implementation of the blood bank's quality system.
The supervision found generally satisfactory operations but identified several minor deviations and one major deviation related to the haemoglobin limit during platelet apheresis, as well as a need for improvements in documentation, training, and storage of reagents.
Supervision at the blood bank (2023)
Conducted by the Norwegian Medicines Agency
The supervision covered the blood bank's operations at several locations and assessed blood collection, virus screening, component production, and quality systems.
The supervision showed that the blood bank is well managed and in compliance with regulations, but identified some minor deviations related to training and assessment of blood donors' suitability.
Supervision of the handling of blood, blood components, cells, and tissues (Health Supervision, 2023)
Conducted by Health Supervision
The supervision assessed the entire chain for handling blood, blood components, human cells, and tissues at Ahus.
No deviations were found, and Health Supervision concluded that Ahus has good and satisfactory routines in all assessed areas.
Medicinal preparedness in Health South-East (2023)
Conducted by the Group Audit in Health South-East (regional level)
The audit assessed regional management of medicinal preparedness, including distribution of responsibilities, emergency plans, storage strategies, and collaboration with Hospital Pharmacies HF.
The audit revealed significant variations between health enterprises, unclear responsibilities at the regional level, and a need for clearer management, follow-up, and coordination of emergency work.
Outsourcing of patients (2023)
Conducted by the Group Audit in Health South-East
The audit assessed whether Ahus has sufficient routines, lines of responsibility, training, and collaboration processes to ensure safe treatment of outsourced patients during overcapacity.
The audit found a substantial extent of outsourcing and identified risks related to unclear responsibilities, inadequate collaboration, missing transfer lists, and insufficient training in receiving units.
Transfer of patients between health enterprises (Ahus–OUS) (2022)
Conducted by the Group Audit in Health South-East
The audit assessed information flow, documentation, and collaboration during the transfer of patients between hospitals.
The audit revealed risks related to inadequate or incomplete information, manual and poorly standardised processes, and weaknesses in digital collaboration that could lead to delays and mismanagement.
Unwanted variation in healthcare services (2021)
Conducted by the Group Audit in Health South-East
The audit assessed how health enterprises use quality data and management information to reduce unwanted variation in treatment, quality, and practice.
The audit identified significant variation between enterprises and professional areas and called for more systematic use of quality registers, stronger management foundations, and better anchoring of improvement work.
